SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764353
Filing Date
2016-11-09
Accepted
2016-11-09 16:12:59
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d446427d10q.htm 10-Q 581092
2 EX-10.1 d446427dex101.htm EX-10.1 55148
3 EX-31.1 d446427dex311.htm EX-31.1 7762
4 EX-31.2 d446427dex312.htm EX-31.2 7635
5 EX-32.1 d446427dex321.htm EX-32.1 5053
12 GRAPHIC g446427g54c50.jpg GRAPHIC 70909
  Complete submission text file 0001193125-16-764353.txt   3144336

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gbt-20160930.xml EX-101.INS 521122
7 XBRL TAXONOMY EXTENSION SCHEMA gbt-20160930.xsd EX-101.SCH 32670
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20160930_cal.xml EX-101.CAL 47720
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20160930_def.xml EX-101.DEF 113606
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20160930_lab.xml EX-101.LAB 287950
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20160930_pre.xml EX-101.PRE 216778
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 161984374
SIC: 2834 Pharmaceutical Preparations